ZyVersa Therapeutics Inc. (ZVSA)

AI Score

Unlock

0.72

0.01 (1.69%)

At close: Apr 24, 2025, 3:59 PM

0.72

0.06%

After-hours: Apr 24, 2025, 07:47 PM EDT

ZyVersa Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Net Income	-9.41B	-2.4M	-2.76M	-2.83M	-13.34M	-2.9M	-78.51M	-3.54M	-4.6M	-3.69M	-2M	-3.75M	-1.97M	-1.88M	-2.1M	-2.14M
Depreciation & Amortization	n/a	6.93M	2.6K	10.44K	2.6K	2.6K	2.6K	2.6K	2.07K	2.6K	2.6K	2.6K	2.6K	2.6K	2.6K	2.6K
Stock-Based Compensation	447.74M	257.44M	160.66K	223.57K	296.71K	243.04K	365.74K	287.46K	393.09K	494.02K	695.94K	1.94M	821.82K	1.4M	1.03K	896.23
Other Working Capital	-1.08M	803.2K	487.92K	-959.24K	-934.06K	944.53K	850.04K	-666K	355.87K	1.33M	56.22K	-69.24K	105.91K	169.92K	-229.96K	-754.32K
Other Non-Cash Items	4.48B	-3.35B	n/a	627.49K	12.25M	22.82K	82.96M	22.05K	1.01M	231.12K	-35.9K	264.86K	65.89K	86.88K	1.45M	1.34M
Deferred Income Tax	-2.96K	9.71M	9.71K	n/a	-596.07K	-485	-7.84M	-1.05M	-745.05K	n/a	n/a	n/a	-12.2K	-459.99K	n/a	n/a
Change in Working Capital	-1.01M	1.59M	676.68K	-1.26M	-1.4M	1.7M	2.61M	-310.56K	3.52M	2.58M	1.03M	1.17M	474.81K	153.59K	-540.91K	-1.11M
Operating Cash Flow	-4.48B	-3.08B	-1.91M	-3.78M	-2.79M	-936.39K	-407.62K	-4.59M	-416.31K	-388.86K	-315.52K	-373.95K	-616.19K	-698.36K	-1.5M	-2.26M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-75.75M	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.7M	n/a	n/a	-2.7M	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.7M	n/a	n/a	-2.7M	-75.75M	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	-1	-230K	-10.47M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	3.03B	2.93B	n/a	2.67M	-653.33K	417.37K	-641.76K	-34.67K	512.88K	-333.6K	296.4K	393.3K	-5.23M	-63.8K	750.56K	5.23M
Financial Cash Flow	3.03B	2.93B	n/a	2.67M	4.35M	2.29M	-641.76K	-34.67K	512.88	662.80	296.40	393.30	76.42M	-63.8K	750.56K	5.23M
Net Cash Flow	1.41B	2.98B	-1.91M	-1.1M	1.56M	1.35M	-1.05M	-4.62M	96.57K	273.94K	-19.12K	19.35K	-616.19K	-698.36K	-1.5K	2.97M
Free Cash Flow	-4.48B	-3.08B	-1.91M	-3.78M	-2.79M	-936.39K	-407.62K	-4.59M	-416.31K	-388.86K	-315.52K	-373.95K	-616.19K	-698.36K	-1.5M	-2.26M